Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
Tibsovo 250 mg, comprimés pelliculés 60
Drug
Tibsovo, comprimés pelliculés
07.16.1. – cytostatics
HAM – Human medicine
FILM – Film-coated tablet
S – synthetic products for human use
A – Dispensed once only on prescription by a physician or veterinarian (A)
Z – approved
6/13/2024
6/12/2029
Dosage strength
Tibsovo 250 mg, comprimés pelliculés
Leucémie myéloïde aiguë (LMA) / Cholangiocarcinome
01
Z – approved
Package
No information made available
A/NR – Authorised / not referenced
60 tablet(s)
001
Z – approved
Declaration
Component
250 mg ivosidenibum
hypromellosi acetas succinas
cellulosum microcristallinum
carmellosum natricum conexum
natrii laurilsulfas
silica colloidalis anhydrica
magnesii stearas
hypromellosum
E 171
10 mg lactosum monohydricum
triacetinum
E 132
max. 5.2 mg natrium
cellulosum microcristallinum
carmellosum natricum conexum
natrii laurilsulfas
silica colloidalis anhydrica
magnesii stearas
hypromellosum
E 171
10 mg lactosum monohydricum
triacetinum
E 132
max. 5.2 mg natrium
Authorisation holder
7601001002371
Servier (Suisse) SA
La Voie-Creuse 16
1202 Genève (GE)
La Voie-Creuse 16
1202 Genève (GE)
Date of revision of the text
7/1/2024
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.